Barbara-Jean Anne Bormann-Kennedy, Director: Xeris Biopharma Holdings XERS Sell · Filed 06/05

Trade details

Type: Insider sale
Amount: $97,440
Shares · price: 16,000 sh · $6.09 a share
Held after: 126,500 sh
Stock: Xeris Biopharma Holdings XERS
Person: Barbara-Jean Anne Bormann-KennedyDirector
Trade date: 26/06/04
Filed: 26/06/05
Days to filing: 1 days

Sold 11.2% of holdings

Share of holding sold: 11.2%

Xeris Biopharma Holdings trades, last 26 weeks

What else happened in Xeris Biopharma Holdings around then

Filed or reported within 30 days of the trade day · 05/05~07/04

Barbara-Jean Anne Bormann-Kennedy's recent trades

Barbara-Jean Anne Bormann-KennedyDirector
Planned sale10b5-1 planXeris Biopharma Holdings
Planned sale10b5-1 plan
Xeris Biopharma Holdings
XERS
$94.2K
16,000 sh
$94.2K
Filed 06/04
Traded 06/04
Barbara-Jean Anne Bormann-KennedyDirector
Sell10b5-1 planXeris Biopharma Holdings
Sell10b5-1 plan
Xeris Biopharma Holdings
XERS
$106.4K
15,000 sh
$106.4K
Filed 25/12/15
Traded 25/12/12
Barbara-Jean Anne Bormann-KennedyDirector
Planned sale10b5-1 planXeris Biopharma Holdings
Planned sale10b5-1 plan
Xeris Biopharma Holdings
XERS
$105.2K
15,000 sh
$105.2K
Filed 25/12/12
Traded 25/12/12